logo
15:47 Dec 05

Albert David Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
783.55
+11.45 (+1.48%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Albert David Ltd. Financials

Albert David Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
783.55
+11.45 (+1.48%)
15:47 Dec 05
Quality
image/svg+xml

36/100
Medium Financial Strength

Valuation
image/svg+xml

23/100
Expensive Valuation

Technical

36/100
Technically Neutral

Strength

5

Weakness

10

Opportunity

0

Threats

0

4.38 %

ROE %

3.36 %

ROA %

-26.42

EPS

687.70

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
313.51 341.56 362.46 345.77 326.98
Operating Expenses +
272.72 297.22 315.58 342.74 335.48
Raw Material
112.56 127.69 128.17 130.61 125.35
Increase Decrease in Cost
2.38 -4.6 -1.77 -14.33 -14.09
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
85.38 81.07 88.43 109.02 109.03
Miscellaneous Expenses
194.6 221.36 229.25 238.36 115.19
Operating Profit
40.79 44.34 46.88 3.03 -8.5
Other Income
15.84 15.4 57.55 29.58 28.56
Depreciation
8.81 8.55 6.83 6.97 7.58
Interest
0.53 0.46 0.32 0.41 0.87
Profit before tax and exceptio..
47.3 50.74 97.29 25.23 11.61
Exceptional Items
0 0 0 0 0
PBT
47.3 50.74 97.29 25.23 11.61
Provision for Taxation
12.04 14.56 21.87 8.03 5.31
Net Profit
35.26 36.17 75.42 17.2 6.29
NET Profit after MI
0 0 0 0 0
EPS
61.78 63.39 132.15 30.14 11.03
Operating Profit Margin (%)
13.01 12.98 12.93 0.88 -2.6
Net Profit Margin (%)
11.25 10.59 20.81 4.97 1.92

Albert David Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 62.20 62.20 62.20 62.10 62.10 62.10
FII 0.60 0.80 1.00 0.90 0.90 0.80
Public 1.60 1.70 1.60 1.60 1.60 1.70
Others 35.60 35.30 35.20 35.40 35.40 35.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: